Stockscreener 앱 받기
1.88
2.73%
0.05
전일 마감가:
$1.83
열려 있는:
$1.83
하루 거래량:
287.29K
Relative Volume:
0.35
시가총액:
$121.79M
수익:
$212.69M
순이익/손실:
$-59.00M
주가수익비율:
-2.0135
EPS:
-0.9337
순현금흐름:
$-29.49M
1주 성능:
-1.57%
1개월 성능:
+29.66%
6개월 성능:
-69.92%
1년 성능:
-74.32%
1일 변동 폭
$1.78
$1.89
1주일 범위
$1.72
$1.9598
52주 변동 폭
$1.17
$7.78
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.88 | 121.79M | 212.69M | -59.00M | -29.49M | -0.9337 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
TMCI SEC FilingsTreace Medical Concepts, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Treace Medical Concepts (TMCI) to Release Earnings on Friday - MarketBeat
Treace Medical Concepts (TMCI) price target increased by 12.28% to 4.08 - MSN
Weber Capital Management LLC ADV Invests $1.45 Million in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to Sell at Wall Street Zen - MarketBeat
Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment - MSN
Treace to Report First Quarter 2026 Financial Results on May 8, 2026 - The Manila Times
Treace Medical Concepts, Inc. to Release First Quarter 2026 Financial Results and Host Conference Call - Quiver Quantitative
Before markets open May 8, Treace will post results and hold an 8 a.m. ET call - Stock Titan
TMCI (Treace Medical Concepts Inc.) notches narrow Q4 2025 EPS beat, shares rise 3.74 percent on positive investor sentiment.Stock Community Signals - UBND thành phố Hải Phòng
Treace Medical Concepts Inc. (TMCI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Treace Medical Concepts (TMCI) CFO reports 11,547-share tax withholding - Stock Titan
Treace Medical Concepts, Inc. (TMCI) LawsuitInvestors Urged to Contact Levi & Korsinsky Before June 10, 2025 - The National Law Review
Wall Street Zen Downgrades Treace Medical Concepts (NASDAQ:TMCI) to Strong Sell - MarketBeat
How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product Plans - Yahoo Finance
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a 127% Potential Upside Amidst Challenges - DirectorsTalk Interviews
TMCI Faces Ownership Changes: Market Reactions Unclear - StocksToTrade
US Stocks Mixed; Dow Falls Over 100 Points - Sahm
Analysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), Evommune, Inc. (EVMN) and BridgeBio Oncology Therapeutics (BBOT) - The Globe and Mail
Wall Street Zen Upgrades Treace Medical Concepts (NASDAQ:TMCI) to Sell - MarketBeat
Chart Watch: Will Treace Medical Concepts Inc outperform tech stocksMarket Performance Report & Verified Momentum Stock Ideas - baoquankhu1.vn
Treace Medical Concepts Announces Leadership Transition and Outlook - The Globe and Mail
Stifel maintains Hold on Treace Medical stock, $3 target unchanged By Investing.com - Investing.com India
Stifel maintains Hold on Treace Medical stock, $3 target unchanged - Investing.com
Market Overview: Will Treace Medical Concepts Inc stock hit new highs in YEARPortfolio Risk Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Treace Medical Concepts, Inc. Reports Q1 2026 Results and Financial Outlook in SEC Form 8-K Filing 10 - Minichart
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 earnings call transcript - MSN
Treace Medical Concepts Incpreliminary Q1 2026 revenue expected at $47.0 million-$47.2 millionSEC filing - marketscreener.com
Treace Medical (NASDAQ: TMCI) raises 2026 sales view as CCO departs - Stock Titan
How does earnings affect Treace (TMCI) Stock | Price at $1.50, Up 6.79%Hot Momentum Watchlist - Cổng thông tin điện tử tỉnh Lào Cai
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System - Ortho Spine News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) stock price, news, quote and history - Yahoo Finance UK
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
Treace Medical Concepts, Inc. Announces First Surgical Cases With The SuperBite Compression Screw System - marketscreener.com
Treace Announces First Surgical Cases with the SuperBite Compression Screw System - Bitget
Is Treace (TMCI) Stock slowing down | Price at $1.34, Down 6.94%Cycle Analysis - UBND thành phố Hải Phòng
Treace Medical Concepts (NASDAQ:TMCI) and PAVmed (NASDAQ:PAVM) Head-To-Head Survey - Defense World
Movement Recap: Is Treace Medical Concepts Inc forming bullish engulfing patterns2026 PostEarnings & Reliable Breakout Forecasts - baoquankhu1.vn
Update Report: How much upside does Treace Medical Concepts Inc haveWeekly Investment Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts (NASDAQ: TMCI) details 2026 virtual annual meeting, votes - Stock Titan
Is Treace (TMCI) Stock Trending Down | Price at $1.43, Down 1.38%Top Analyst Picks - Cổng thông tin điện tử tỉnh Lào Cai
TMCI PE Ratio & Valuation, Is TMCI Overvalued - Intellectia AI
Treace Medical Concepts (TMCI) price target decreased by 10.94% to 3.63 - MSN
CFO at Treace Medical (TMCI) granted 100,000 performance stock units - Stock Titan
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.93%
자본화:
|
볼륨(24시간):